Cortisone-induced islet cell hyperplasia in hamsters

Area of Science:

• Endocrinology
• Cell Biology
• Metabolic Research

Background:

• Glucocorticoids, like cortisone, are known to affect glucose metabolism.
• Pancreatic islet cells play a crucial role in regulating blood glucose levels.
• The long-term effects of cortisone on pancreatic islet cell function and morphology require further investigation.

Purpose of the Study:

• To investigate the effects of prolonged cortisone administration on pancreatic islet cell hyperplasia in hamsters.
• To analyze changes in serum glucose and insulin levels, as well as pancreatic hormone concentrations (insulin, glucagon, somatostatin, pancreatic polypeptide).
• To examine islet tissue morphometry and cellular changes, particularly in beta cells.

Main Methods:

• Hamsters were treated with cortisone for one to eight weeks.
• Measurements included serum glucose and insulin.
• Pancreatic tissues were analyzed for insulin, glucagon, somatostatin, and pancreatic polypeptide content, along with detailed islet morphometry.

Main Results:

• Cortisone treatment led to initial hyperglycemia, followed by sustained elevated serum insulin levels.
• Pancreatic insulin content peaked at week 5 and subsequently declined, coinciding with beta cell neurosis in hyperplastic islets.
• Glucagon levels were reduced, while somatostatin and pancreatic polypeptide showed moderate increases compared to controls.

Conclusions:

• Cortisone induces significant changes in pancreatic islet cell populations, characterized by beta cell hyperplasia.
• The observed beta cell hyperplasia appears to be a compensatory response to decreased insulin binding at target organs, not a change in receptor concentration.
• These findings highlight the complex interplay between glucocorticoids and pancreatic islet cell function in metabolic regulation.